Trial Profile
Effects of rosuvastatin +/- ramipril on atheroma volume in patients with de novo intermediate coronary artery disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Aug 2012
Price :
$35
*
At a glance
- Drugs Ramipril (Primary) ; Rosuvastatin (Primary)
- Indications Coronary artery disease
- Focus Biomarker; Pharmacodynamics
- 08 Aug 2012 New trial record
- 12 Jul 2012 Results published in the International Journal of Cardiology.